Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Davis

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Bladder (San Francisco, Calif.)|August 11, 2020
Increased utilization of external beam radiotherapy relative to cystectomy for localized, muscle-invasive bladder cancer: a SEER analysisTyler J Wilhite, David Routman, Andrea L Arnett, et al.
The Lancet. Oncology|August 31, 2016
HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort studyJason W D Hearn, Ghada AbuAli, Chad A Reichard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 2, 2005
A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancerRoisin M Dwyer, Stephen M Schatz, Elizabeth R Bergert, et al.
Brachytherapy|June 2, 2014
Response to Drs Rogers, Hayes, and DemanesI-Chow Joe Hsu, Yoshiya Yamada, Dean G Assimos, et al.
Brachytherapy|October 9, 2018
Permanent prostate brachytherapy monotherapy with I-125 for low- and intermediate-risk prostate cancer: Outcomes in 974 patientsDavid M Routman, Ryan K Funk, Bradley J Stish, et al.
Brachytherapy|December 26, 2013
ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancerI-Chow Joe Hsu, Yoshiya Yamada, Dean G Assimos, et al.
Oncology (Williston Park, N.Y.)|December 17, 2014
ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancerGary S Gustafson, Paul L Nguyen, Dean G Assimos, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed TomographyWilliam P Parker, Jaden D Evans, Bradley J Stish, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 11, 2014
Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in miceDaniel J Morgan, Brian J Davis, Chris S Kearn, et al.
Advances in Radiation Oncology|February 2, 2019
Percutaneous Image-Guided Nodal Biopsy After 11C-Choline PET/CT for Biochemically Recurrent Prostate Cancer: Imaging Predictors of Disease and Clinical ImplicationsBrian T Welch, Ann T Packard, Thomas D Atwell, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Bladder (San Francisco, Calif.)|August 11, 2020
Increased utilization of external beam radiotherapy relative to cystectomy for localized, muscle-invasive bladder cancer: a SEER analysisTyler J Wilhite, David Routman, Andrea L Arnett, et al.
The Lancet. Oncology|August 31, 2016
HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort studyJason W D Hearn, Ghada AbuAli, Chad A Reichard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 2, 2005
A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancerRoisin M Dwyer, Stephen M Schatz, Elizabeth R Bergert, et al.
Brachytherapy|June 2, 2014
Response to Drs Rogers, Hayes, and DemanesI-Chow Joe Hsu, Yoshiya Yamada, Dean G Assimos, et al.
Brachytherapy|October 9, 2018
Permanent prostate brachytherapy monotherapy with I-125 for low- and intermediate-risk prostate cancer: Outcomes in 974 patientsDavid M Routman, Ryan K Funk, Bradley J Stish, et al.
Brachytherapy|December 26, 2013
ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancerI-Chow Joe Hsu, Yoshiya Yamada, Dean G Assimos, et al.
Oncology (Williston Park, N.Y.)|December 17, 2014
ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancerGary S Gustafson, Paul L Nguyen, Dean G Assimos, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed TomographyWilliam P Parker, Jaden D Evans, Bradley J Stish, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 11, 2014
Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in miceDaniel J Morgan, Brian J Davis, Chris S Kearn, et al.
Advances in Radiation Oncology|February 2, 2019
Percutaneous Image-Guided Nodal Biopsy After 11C-Choline PET/CT for Biochemically Recurrent Prostate Cancer: Imaging Predictors of Disease and Clinical ImplicationsBrian T Welch, Ann T Packard, Thomas D Atwell, et al.
Pageof 15